|

ECT204 T cells Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • Eureka Therapeutics Inc.1

Indications

  • Liver Disease1
  • Liver Neoplasm1
  • Metastatic Liver Cancer1
  • Liver Cancer, Adult1
  • Liver Cancer1

Duarte, California1 trial

T-Cell Therapy (ECT204) in Adults With Advanced HCC

City of Hope

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.